Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Malignant Melanoma

Free Subscription Articles published in Melanoma Res Retrieve available abstracts of 144 articles: HTML format

Single Articles

April 2008
1. GARBE C , Hauschild A, Volkenandt M, Schadendorf D, et al
   Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting.
   Melanoma Res. 2008;18:152-160.
   PubMed     Related articles    Abstract available
   
   
   
2. BAEL TE , Peterson BL, Gollob JA
   Phase II trial of arsenic trioxide and ascorbic acid with temozolomide in patients with metastatic melanoma with or without central nervous system metastases.
   Melanoma Res. 2008;18:147-51.
   PubMed     Related articles    Abstract available
   
   
   
3. GUILLOT B , Khamari A, Cupissol D, Delaunay M, et al
   Temozolomide associated with PEG-interferon in patients with metastatic melanoma: a multicenter prospective phase I/II study.
   Melanoma Res. 2008;18:141-146.
   PubMed     Related articles    Abstract available
   
   
   
4. FAYE RS , Paus E, Maelandsmo GM, Berner A, et al
   S100B in bone marrow aspirates in healthy individuals and malignant melanoma patients.
   Melanoma Res. 2008;18:134-40.
   PubMed     Related articles    Abstract available
   
   
   
5. DE SIMONE P , Silipo V, Buccini P, Mariani G, et al
   Vulvar melanoma: a report of 10 cases and review of the literature.
   Melanoma Res. 2008;18:127-33.
   PubMed     Related articles    Abstract available
   
   
   
6. RIZELL M , Mattson J, Cahlin C, Hafstrom L, et al
   Isolated hepatic perfusion for liver metastases of malignant melanoma.
   Melanoma Res. 2008;18:120-6.
   PubMed     Related articles    Abstract available
   
   
   
7. SCHWAGER SS , Leiter U, Buettner PG, Voit C, et al
   Management of primary and metastasized melanoma in Germany in the time period 1976-2005: an analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
   Melanoma Res. 2008;18:112-119.
   PubMed     Related articles    Abstract available
   
   
   
8. YANG H , Fang G, Huang X, Yu J, et al
   In-vivo xenograft murine human uveal melanoma model develops hepatic micrometastases.
   Melanoma Res. 2008;18:95-103.
   PubMed     Related articles    Abstract available
   
   
   
9. SAITO A , Saito N, Mol W, Furukawa H, et al
   Simvastatin inhibits growth via apoptosis and the induction of cell cycle arrest in human melanoma cells.
   Melanoma Res. 2008;18:85-94.
   PubMed     Related articles    Abstract available
   
   
   
10. SCHWENKERT M , Birkholz K, Schwemmlein M, Kellner C, et al
    A single chain immunotoxin, targeting the melanoma-associated chondroitin sulfate proteoglycan, is a potent inducer of apoptosis in cultured human melanoma cells.
    Melanoma Res. 2008;18:73-84.
    PubMed     Related articles    Abstract available
    
    
    February 2008
11. CABIBI D , Cacciatore M, Russo L, Porcasi R, et al
    The oral melanoma: atypical immunophenotype in the metastatic area.
    Melanoma Res. 2008;18:70-2.
    PubMed     Related articles   
    
    
    
12. GARBE C , Hauschild A, Volkenandt M, Schadendorf D, et al
    Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma.
    Melanoma Res. 2008;18:61-67.
    PubMed     Related articles    Abstract available
    
    
    
13. CONSTANTINIDOU A , Hofman M, O'doherty M, Acland KM, et al
    Routine positron emission tomography and positron emission tomography/computed tomography in melanoma staging with positive sentinel node biopsy is of limited benefit.
    Melanoma Res. 2008;18:56-60.
    PubMed     Related articles    Abstract available
    
    
    
14. RAVINDRANATH MH , Muthugounder S, Presser N
    Ganglioside signatures of primary and nodal metastatic melanoma cell lines from the same patient.
    Melanoma Res. 2008;18:47-55.
    PubMed     Related articles    Abstract available
    
    
    
15. CHEVALIER J , Bonastre J, Avril MF
    The economic burden of melanoma in France: assessing healthcare use in a hospital setting.
    Melanoma Res. 2008;18:40-6.
    PubMed     Related articles    Abstract available
    
    
    
16. AKSLEN LA , Puntervoll H, Bachmann IM, Straume O, et al
    Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma.
    Melanoma Res. 2008;18:29-35.
    PubMed     Related articles    Abstract available
    
    
    
17. KRETSCHMER L , Thoms KM, Peeters S, Haenssle H, et al
    Postoperative morbidity of lymph node excision for cutaneous melanoma-sentinel lymphonodectomy versus complete regional lymph node dissection.
    Melanoma Res. 2008;18:16-21.
    PubMed     Related articles    Abstract available
    
    
    
18. VAN GILS W , Kilic E, Bruggenwirth HT, Vaarwater J, et al
    Regional deletion and amplification on chromosome 6 in a uveal melanoma case without abnormalities on chromosomes 1p, 3 and 8.
    Melanoma Res. 2008;18:10-5.
    PubMed     Related articles    Abstract available
    
    
    
19. VEIEROD MB , Parr CL, Lund E, Hjartaker A, et al
    Reproducibility of self-reported melanoma risk factors in a large cohort study of Norwegian women.
    Melanoma Res. 2008;18:1-9.
    PubMed     Related articles    Abstract available
    
    
    
20. SCHAFER-HESTERBERG G , Voit C
    Ultrasound pre sentinel node dissection.
    Melanoma Res. 2008;18:68-9.
    PubMed     Related articles   
    
    
    
21. MILNE E , Simpson JA, English DR
    Appearance of melanocytic nevi on the backs of young Australian children: a 7-year longitudinal study.
    Melanoma Res. 2008;18:22-8.
    PubMed     Related articles    Abstract available
    
    
    December 2007
22. OMHOLT K , Hansson J
    No evidence of RALGDS mutations in cutaneous melanoma.
    Melanoma Res. 2007;17:410-2.
    PubMed     Related articles   
    
    
    
23. WITTGEN HG , van Kempen LC
    Reactive oxygen species in melanoma and its therapeutic implications.
    Melanoma Res. 2007;17:400-9.
    PubMed     Related articles    Abstract available
    
    
    
24. GARBE C , Hauschild A, Volkenandt M, Schadendorf D, et al
    Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
    Melanoma Res. 2007;17:393-399.
    PubMed     Related articles    Abstract available
    
    
    
25. GENSINI F , Sestini R, Piazzini M, Vignoli M, et al
    The p.G23S CDKN2A founder mutation in high-risk melanoma families from Central Italy.
    Melanoma Res. 2007;17:387-392.
    PubMed     Related articles    Abstract available
    
    
    
26. ZUIDERVAART W , Pavey S, van Nieuwpoort FA, Packer L, et al
    Expression of Wnt5a and its downstream effector beta-catenin in uveal melanoma.
    Melanoma Res. 2007;17:380-6.
    PubMed     Related articles    Abstract available
    
    
    
27. VARTANIAN AA , Burova OS, Stepanova EV, Baryshnikov AY, et al
    Melanoma vasculogenic mimicry is strongly related to reactive oxygen species level.
    Melanoma Res. 2007;17:370-9.
    PubMed     Related articles    Abstract available
    
    
    
28. SHPITZER T , Gutman H, Barnea Y, Steinmetz A, et al
    Sentinel node-guided evaluation of drainage patterns for melanoma of the helix of the ear.
    Melanoma Res. 2007;17:365-369.
    PubMed     Related articles    Abstract available
    
    
    
29. REICHLE A , Vogt T, Coras B, Terheyden P, et al
    Targeted combined anti-inflammatory and angiostatic therapy in advanced melanoma: a randomized phase II trial.
    Melanoma Res. 2007;17:360-364.
    PubMed     Related articles    Abstract available
    
    
    
30. GUTKOWICZ-KRUSIN D , Rabinovitz HS
    Kinetic model of progression of cutaneous melanoma population.
    Melanoma Res. 2007;17:354-9.
    PubMed     Related articles    Abstract available
    
    
    
31. BASTIAANNET E , Homan-van der Heide JJ, Ploeg RJ, Hoekstra HJ, et al
    No increase of melanoma after kidney transplantation in the northern part of The Netherlands.
    Melanoma Res. 2007;17:349-53.
    PubMed     Related articles    Abstract available
    
    
    
32. ZAMORA-AVILA DE , Franco-Molina MA, Trejo-Avila LM, Rodriguez-Padilla C, et al
    RNAi silencing of the WT1 gene inhibits cell proliferation and induces apoptosis in the B16F10 murine melanoma cell line.
    Melanoma Res. 2007;17:341-8.
    PubMed     Related articles    Abstract available
    
    
    October 2007
33. ALBERT JG , Gimm O, Stock K, Bilkenroth U, et al
    Small-bowel endoscopy is crucial for diagnosis of melanoma metastases to the small bowel: a case of metachronous small-bowel metastases and review of the literature.
    Melanoma Res. 2007;17:335-8.
    PubMed     Related articles   
    
    
    
34. DEL VECCHIO M , Canova S, Messina A, Bajetta E, et al
    Impressive objective response in a patient with extensive metastatic melanoma including the brain.
    Melanoma Res. 2007;17:332-4.
    PubMed     Related articles   
    
    
    
35. BAUR M , Gneist M, Owa T, Dittrich C, et al
    Clinical complete long-term remission of a patient with metastatic malignant melanoma under therapy with indisulam (E7070).
    Melanoma Res. 2007;17:329-331.
    PubMed     Related articles    Abstract available
    
    
    
36. COVARELLI P , Tomassini GM, Simonetti S, Messina S, et al
    The single-photon emission computed tomography/computed tomography: a new procedure to perform the sentinel node biopsy in patients with head and neck melanoma.
    Melanoma Res. 2007;17:323-8.
    PubMed     Related articles    Abstract available
    
    
    
37. O'ROURKE MG , Johnson MK, Lanagan CM, See JL, et al
    Dendritic cell immunotherapy for stage IV melanoma.
    Melanoma Res. 2007;17:316-322.
    PubMed     Related articles    Abstract available
    
    
    
38. ELIAS EG , Zapas JL, Beam SL, Culpepper WJ, et al
    Perioperative adjuvant biotherapy in high-risk resected cutaneous melanoma: the results of 5 years of follow-up.
    Melanoma Res. 2007;17:310-5.
    PubMed     Related articles    Abstract available
    
    
    
39. CONILL C , Jorcano S, Domingo-Domenech J, Marruecos J, et al
    Toxicity of combined treatment of adjuvant irradiation and interferon alpha2b in high-risk melanoma patients.
    Melanoma Res. 2007;17:304-309.
    PubMed     Related articles    Abstract available
    
    
    
40. SCHWEITZER AD , Rakesh V, Revskaya E, Datta A, et al
    Computational model predicts effective delivery of 188-Re-labeled melanin-binding antibody to metastatic melanoma tumors with wide range of melanin concentrations.
    Melanoma Res. 2007;17:291-303.
    PubMed     Related articles    Abstract available
    
    
    
41. BAKALIAN S , Marshall JC, Faingold D, Logan P, et al
    Expression of nm23-H1 in uveal melanoma.
    Melanoma Res. 2007;17:284-90.
    PubMed     Related articles    Abstract available
    
    
    
42. MARIN YE , Wall BA, Wang S, Namkoong J, et al
    Curcumin downregulates the constitutive activity of NF-kappaB and induces apoptosis in novel mouse melanoma cells.
    Melanoma Res. 2007;17:274-283.
    PubMed     Related articles    Abstract available
    
    
    
43. HEIMERL S , Bosserhoff AK, Langmann T, Ecker J, et al
    Mapping ATP-binding cassette transporter gene expression profiles in melanocytes and melanoma cells.
    Melanoma Res. 2007;17:265-73.
    PubMed     Related articles    Abstract available
    
    
    August 2007
44. HEMRAJANI RH , Kim KB, Amos WR, Mann DE, et al
    Use of sargramostim as maintenance therapy in patients with stage IV melanoma at high risk for systemic recurrence.
    Melanoma Res. 2007;17:257-259.
    PubMed     Related articles   
    
    
    
45. COHEN VM , Ahmadi-Lari S, Hungerford JL
    Gastric metastases from conjunctival melanoma.
    Melanoma Res. 2007;17:255-256.
    PubMed     Related articles    Abstract available
    
    
    
46. SZELL M , Balogh K, Dobozy A, Kemeny L, et al
    First detection of the melanoma-predisposing proline-48-threonine mutation of p16 in Hungarians: was there a common founder either in Italy or in Hungary?
    Melanoma Res. 2007;17:251-4.
    PubMed     Related articles    Abstract available
    
    
    
47. BAADE PD , Youl PH, English DR, Mark Elwood J, et al
    Clinical pathways to diagnose melanoma: a population-based study.
    Melanoma Res. 2007;17:243-9.
    PubMed     Related articles    Abstract available
    
    
    
48. LI B , Lei W, Shao K, Zhang C, et al
    Characteristics and prognosis of primary malignant melanoma of the esophagus.
    Melanoma Res. 2007;17:239-42.
    PubMed     Related articles    Abstract available
    
    
    
49. SIBON C , Chagnon S, Tchakerian A, Bafounta ML, et al
    The contribution of high-resolution ultrasonography in preoperatively detecting sentinel-node metastases in melanoma patients.
    Melanoma Res. 2007;17:233-7.
    PubMed     Related articles    Abstract available
    
    
    
50. SOLTI M , Berd D, Mastrangelo MJ, Sato T, et al
    A pilot study of low-dose thalidomide and interferon alpha-2b in patients with metastatic melanoma who failed prior treatment.
    Melanoma Res. 2007;17:225-31.
    PubMed     Related articles    Abstract available
    
    
    
51. VUORISTO M , Vihinen P, Vlaykova T, Nylund C, et al
    Increased gene expression levels of collagen receptor integrins are associated with decreased survival parameters in patients with advanced melanoma.
    Melanoma Res. 2007;17:215-223.
    PubMed     Related articles    Abstract available
    
    
    
52. IIDA J , McCarthy JB
    Expression of collagenase-1 (MMP-1) promotes melanoma growth through the generation of active transforming growth factor-beta.
    Melanoma Res. 2007;17:205-13.
    PubMed     Related articles    Abstract available
    
    
    
53. BRYAN J , Nieweg OE
    New boundaries for lymphatic mapping-report of the Fifth International Sentinel Node Conference.
    Melanoma Res. 2007;17:261-3.
    PubMed     Related articles    Abstract available
    
    
    June 2007
54. KLUGER N , Riviere S, Coupier I, Bessis D, et al
    Association of hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber syndrome) and malignant melanoma in two patients.
    Melanoma Res. 2007;17:201-203.
    PubMed     Related articles    Abstract available
    
    
    
55. MOSCHOS SJ , Odoux C, Land SR, Agarwala S, et al
    Endostatin plus interferon-alpha2b therapy for metastatic melanoma: a novel combination of antiangiogenic and immunomodulatory agents.
    Melanoma Res. 2007;17:193-200.
    PubMed     Related articles    Abstract available
    
    
    
56. PJANOVA D , Engele L, Randerson-Moor JA, Harland M, et al
    CDKN2A and CDK4 variants in Latvian melanoma patients: analysis of a clinic-based population.
    Melanoma Res. 2007;17:185-191.
    PubMed     Related articles    Abstract available
    
    
    
57. RUSCIANI L , Proietti I, Paradisi A, Rusciani A, et al
    Recombinant interferon alpha-2b and coenzyme Q10 as a postsurgical adjuvant therapy for melanoma: a 3-year trial with recombinant interferon-alpha and 5-year follow-up.
    Melanoma Res. 2007;17:177-83.
    PubMed     Related articles    Abstract available
    
    
    
58. PREYNAT-SEAUVE O , Contassot E, Schuler P, French LE, et al
    Melanoma-infiltrating dendritic cells induce protective antitumor responses mediated by T cells.
    Melanoma Res. 2007;17:169-76.
    PubMed     Related articles    Abstract available
    
    
    
59. FONTIJN D , Duyndam MC, Belien JA, Gallegoz Ruiz MI, et al
    The 18 kDa isoform of basic fibroblast growth factor is sufficient to stimulate human melanoma growth and angiogenesis.
    Melanoma Res. 2007;17:155-68.
    PubMed     Related articles    Abstract available
    
    
    
60. MAUBEC E , Lumbroso J, Masson F, Suciu V, et al
    F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4 mm.
    Melanoma Res. 2007;17:147-54.
    PubMed     Related articles    Abstract available
    
    
    
61. CHWIROT BW , Kuzbicki L
    Cyclooxygenase-2 (COX-2): first immunohistochemical marker distinguishing early cutaneous melanomas from benign melanocytic skin tumours.
    Melanoma Res. 2007;17:139-45.
    PubMed     Related articles    Abstract available
    
    
    
62. STORKUS WJ
    Melanoma vaccines: in search of a clinical paradigm.
    Melanoma Res. 2007;17:137-8.
    PubMed     Related articles   
    
    
    April 2007
63. MNICH CD , Hoek KS, Oberholzer PA, Seifert B, et al
    Reduced pSmad2 immunodetection correlates with increased primary melanoma thickness.
    Melanoma Res. 2007;17:131-6.
    PubMed     Related articles    Abstract available
    
    
    
64. CHELLINI E , Crocetti E, Carli P, Martini A, et al
    The melanoma epidemic debate: some evidence for a real phenomenon from Tuscany, Italy.
    Melanoma Res. 2007;17:129-30.
    PubMed     Related articles    Abstract available
    
    
    
65. GARBE C , Eigentler TK
    Diagnosis and treatment of cutaneous melanoma: state of the art 2006.
    Melanoma Res. 2007;17:117-27.
    PubMed     Related articles    Abstract available
    
    
    
66. MEYER P , Stapelmann H, Frank B, Varon R, et al
    Molecular genetic analysis of NBS1 in German melanoma patients.
    Melanoma Res. 2007;17:109-16.
    PubMed     Related articles    Abstract available
    
    
    
67. GALORE G , Azizi E, Scope A, Pavlotsky F, et al
    The Y152X MC1R gene mutation: occurrence in ethnically diverse Jewish malignant melanoma patients.
    Melanoma Res. 2007;17:105-8.
    PubMed     Related articles    Abstract available
    
    
    
68. UEDA Y , Su Y, Richmond A
    CCAAT displacement protein regulates nuclear factor-kappa beta-mediated chemokine transcription in melanoma cells.
    Melanoma Res. 2007;17:91-103.
    PubMed     Related articles    Abstract available
    
    
    
69. VISUS C , Andres R, Mayordomo JI, Martinez-Lorenzo MJ, et al
    Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma.
    Melanoma Res. 2007;17:83-9.
    PubMed     Related articles    Abstract available
    
    
    
70. QUAGLINO P , Osella-Abate S, Cappello N, Ortoncelli M, et al
    Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients.
    Melanoma Res. 2007;17:75-82.
    PubMed     Related articles    Abstract available
    
    
    
71. WOLF M , Bauder-Wust U, Eskerski H, Bauer C, et al
    Role of acidic cell organelles in the higher nonmelanoma retention of melanoma markers based on N-(2-dialkylaminoethyl)benzamides and the cytotoxicity of alkylating benzamides.
    Melanoma Res. 2007;17:61-73.
    PubMed     Related articles    Abstract available
    
    
    February 2007
72. CLARK RR , Shoaib T
    Sentinel lymph node biopsy: a new perspective in head and neck mucosal melanoma?
    Melanoma Res. 2007;17:59.
    PubMed     Related articles   
    
    
    
73. RINGBORG U , Pownall M
    Interferon therapy discussed at the Sixth International Conference on the Adjuvant Therapy of Malignant Melanoma, Stockholm, Sweden, 15-17 June 2006.
    Melanoma Res. 2007;17:56-8.
    PubMed     Related articles   
    
    
    
74. LEE TK , Brazier AS, Shoveller JA, Gallagher RP, et al
    Sun-related behavior after a diagnosis of cutaneous malignant melanoma.
    Melanoma Res. 2007;17:51-5.
    PubMed     Related articles    Abstract available
    
    
    
75. ELMORE E , Jain A, Siddiqui S, Tohidian N, et al
    Development and characteristics of a human cell assay for screening agents for melanoma prevention.
    Melanoma Res. 2007;17:42-50.
    PubMed     Related articles    Abstract available
    
    
    
76. KOYNOVA DK , Jordanova ES, Milev AD, Dijkman R, et al
    Gene-specific fluorescence in-situ hybridization analysis on tissue microarray to refine the region of chromosome 20q amplification in melanoma.
    Melanoma Res. 2007;17:37-41.
    PubMed     Related articles    Abstract available
    
    
    
77. LANGAGERGAARD V , Puho EH, Lash TL, Norgard B, et al
    Birth outcome in Danish women with cutaneous malignant melanoma.
    Melanoma Res. 2007;17:31-36.
    PubMed     Related articles    Abstract available
    
    
    
78. OPPITZ M , Busch C, Schriek G, Metzger M, et al
    Non-malignant migration of B16 mouse melanoma cells in the neural crest and invasive growth in the eye cup of the chick embryo.
    Melanoma Res. 2007;17:17-30.
    PubMed     Related articles    Abstract available
    
    
    
79. CHAKRABORTY AK , Pawelek J
    beta1,6-branched oligosaccharides regulate melanin content and motility in macrophage-melanoma fusion hybrids.
    Melanoma Res. 2007;17:9-16.
    PubMed     Related articles    Abstract available
    
    
    
80. VARTANIAN AA , Burova OS, Stepanova EV, Baryshnikov AY, et al
    The involvement of apoptosis in melanoma vasculogenic mimicry.
    Melanoma Res. 2007;17:1-8.
    PubMed     Related articles    Abstract available
    
    
    December 2006
81. TURRISI G , Sozzi P, Marinozzi C, Clerico MA, et al
    Persistent thrombocytopenia during melanoma treatment with fotemustine.
    Melanoma Res. 2006;16:543-544.
    PubMed     Related articles    Abstract available
    
    
    
82. MARSHALL JC , Gordon KD, McCauley CS, de Souza Filho JP, et al
    The effect of blue light exposure and use of intraocular lenses on human uveal melanoma cell lines.
    Melanoma Res. 2006;16:537-41.
    PubMed     Related articles    Abstract available
    
    
    
83. KISSEL CK , Schadendorf D, Rockmann H
    The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific.
    Melanoma Res. 2006;16:527-35.
    PubMed     Related articles    Abstract available
    
    
    
84. GONZALEZ R , Hutchins L, Nemunaitis J, Atkins M, et al
    Phase 2 trial of Allovectin-7 in advanced metastatic melanoma.
    Melanoma Res. 2006;16:521-526.
    PubMed     Related articles    Abstract available
    
    
    
85. LIN SY , Lai WW, Chou CC, Kuo HM, et al
    Sodium ascorbate inhibits growth via the induction of cell cycle arrest and apoptosis in human malignant melanoma A375.S2 cells.
    Melanoma Res. 2006;16:509-519.
    PubMed     Related articles    Abstract available
    
    
    
86. BALDINI PM , Lentini A, Mattioli P, Provenzano B, et al
    Decrease of polyamine levels and enhancement of transglutaminase activity in selective reduction of B16-F10 melanoma cell proliferation induced by atrial natriuretic peptide.
    Melanoma Res. 2006;16:501-507.
    PubMed     Related articles    Abstract available
    
    
    
87. SILIPO V , De Simone P, Mariani G, Buccini P, et al
    Malignant melanoma and pregnancy.
    Melanoma Res. 2006;16:497-500.
    PubMed     Related articles    Abstract available
    
    
    
88. WOLF M , Eskerski H, Bauder-Wust U, Haberkorn U, et al
    Alkylating benzamides with melanoma cytotoxicity: experimental chemotherapy in a mouse melanoma model.
    Melanoma Res. 2006;16:487-96.
    PubMed     Related articles    Abstract available
    
    
    
89. HARTMANN P , Mirtolouei R, Untersberger S, Ziegler W, et al
    Non-invasive imaging of tissue PO2 in malignant melanoma of the skin.
    Melanoma Res. 2006;16:479-86.
    PubMed     Related articles    Abstract available
    
    
    
90. EDLUNDH-ROSE E , Egyha Zi S, Omholt K, Mansson-Brahme E, et al
    NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing.
    Melanoma Res. 2006;16:471-478.
    PubMed     Related articles    Abstract available
    
    
    October 2006
91. BUDA G , Romagnoli MC, Galimberti S, Figus M, et al
    Simultaneous appearance of acute myeloid leukemia in a patient with bilateral primary uveal melanoma.
    Melanoma Res. 2006;16:467-8.
    PubMed     Related articles    Abstract available
    
    
    
92. WILSON KS
    Cyclooxygenase-2 inhibition and regression of metastatic melanoma.
    Melanoma Res. 2006;16:465.
    PubMed     Related articles   
    
    
    
93. DOHERTY SD , Prieto VG, George S, Hazarika P, et al
    High flotillin-2 expression is associated with lymph node metastasis and Breslow depth in melanoma.
    Melanoma Res. 2006;16:461-3.
    PubMed     Related articles   
    
    
    
94. HILLEN F , van de Winkel A, Creytens D, Vermeulen AH, et al
    Proliferating endothelial cells, but not microvessel density, are a prognostic parameter in human cutaneous melanoma.
    Melanoma Res. 2006;16:453-7.
    PubMed     Related articles    Abstract available
    
    
    
95. LEE J , Duk Jung I, Gyo Park C, Han JW, et al
    Autotaxin stimulates urokinase-type plasminogen activator expression through phosphoinositide 3-kinase-Akt-necrosis factor kappa B signaling cascade in human melanoma cells.
    Melanoma Res. 2006;16:445-52.
    PubMed     Related articles    Abstract available
    
    
    
96. KUZBICKI L , Aladowicz E, Chwirot BW
    Cyclin-dependent kinase 2 expression in human melanomas and benign melanocytic skin lesions.
    Melanoma Res. 2006;16:435-44.
    PubMed     Related articles    Abstract available
    
    
    
97. CROCETTI E , Mangone L, Scocco GL, Carli P, et al
    Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study.
    Melanoma Res. 2006;16:429-433.
    PubMed     Related articles    Abstract available
    
    
    
98. STA REK I , Koranda P, Benes P
    Sentinel lymph node biopsy: a new perspective in head and neck mucosal melanoma?
    Melanoma Res. 2006;16:423-7.
    PubMed     Related articles    Abstract available
    
    
    
99. PFOHLER C , Tschop S, Konig J, Rass K, et al
    Frequency of colour vision deficiencies in melanoma patients: results of a prospective comparative screening study with the Farnsworth panel D 15 test including 300 melanoma patients and 100 healthy controls.
    Melanoma Res. 2006;16:413-21.
    PubMed     Related articles    Abstract available
    
    
    
100. TAS F , Duranyildiz D, Oguz H, Camlica H, et al
     Circulating serum levels of angiogenic factors and vascular endothelial growth factor receptors 1 and 2 in melanoma patients.
     Melanoma Res. 2006;16:405-11.
     PubMed     Related articles    Abstract available
     
     
     
101. KIPPENBERGER S , Loitsch S, Thaci D, Muller J, et al
     Restoration of E-cadherin sensitizes human melanoma cells for apoptosis.
     Melanoma Res. 2006;16:393-403.
     PubMed     Related articles    Abstract available
     
     
     
102. ADAM B , Toth L, Pasti G, Balazs M, et al
     Contact stimulation of fibroblasts for tenascin production by melanoma cells.
     Melanoma Res. 2006;16:385-91.
     PubMed     Related articles    Abstract available
     
     
     
103. LEJEUNE FJ
     Editorial: anticytotoxic T lymphocyte-associated antigen 4 treatment - can melanoma be cured at the expense of autoimmune disorders?
     Melanoma Res. 2006;16:377-8.
     PubMed     Related articles   
     
     
     
104. GRUNWALD MH , Gat A, Amichai B
     Pseudomelanoma after Solcoderm treatment.
     Melanoma Res. 2006;16:459-60.
     PubMed     Related articles    Abstract available
     
     
     
105. WEBER JS
     The clinical utility of cytotoxic T lymphocyte antigen 4 abrogation by human antibodies.
     Melanoma Res. 2006;16:379-83.
     PubMed     Related articles    Abstract available
     
     
     August 2006
106. PARADISI A , Capizzi R, De Simone C, Fossati B, et al
     Malignant melanoma in a tattoo: case report and review of the literature.
     Melanoma Res. 2006;16:375-6.
     PubMed     Related articles    Abstract available
     
     
     
107. DANESHPAZHOOH M , Shokoohi A, Dadban A, Raafat J, et al
     The course of melanoma-associated vitiligo: report of a case.
     Melanoma Res. 2006;16:371-3.
     PubMed     Related articles    Abstract available
     
     
     
108. GARCIA M , Del Muro XG, Tres A, Crespo C, et al
     Phase II multicentre study of temozolomide in combination with interferon alpha-2b in metastatic malignant melanoma.
     Melanoma Res. 2006;16:365-370.
     PubMed     Related articles    Abstract available
     
     
     
109. MASUCCI GV , Mansson-Brahme E, Ragnarsson-Olding B, Nilsson B, et al
     Alternating chemo-immunotherapy with temozolomide and low-dose interleukin-2 in patients with metastatic melanoma.
     Melanoma Res. 2006;16:357-63.
     PubMed     Related articles    Abstract available
     
     
     
110. LIM E , Browning J, Macgregor D, Davis ID, et al
     Desmoplastic melanoma: comparison of expression of differentiation antigens and cancer testis antigens.
     Melanoma Res. 2006;16:347-55.
     PubMed     Related articles    Abstract available
     
     
     
111. MOUAWAD R , Soubrane C, Rixe O, Khayat D, et al
     An unexpected inverse correlation between soluble epidermal growth factor receptor and interleukin-6 in metastatic malignant melanoma patients.
     Melanoma Res. 2006;16:335-40.
     PubMed     Related articles    Abstract available
     
     
     
112. JOSEPH-PIETRAS D , Carlier A, Madoulet C, Albert P, et al
     Anti-tumoural activity of peripheral blood mononuclear cells against melanoma cells: discrepant in-vitro and in-vivo effects.
     Melanoma Res. 2006;16:325-33.
     PubMed     Related articles    Abstract available
     
     
     
113. GUIDA M , Riccobon A, Biasco G, Ravaioli A, et al
     Basal level and behaviour of cytokines in a randomized outpatient trial comparing chemotherapy and biochemotherapy in metastatic melanoma.
     Melanoma Res. 2006;16:317-323.
     PubMed     Related articles    Abstract available
     
     
     
114. ROTHHAMMER T , Bosserhoff AK
     Influence of melanoma inhibitory activity on transforming growth factor-beta signaling in malignant melanoma.
     Melanoma Res. 2006;16:309-16.
     PubMed     Related articles    Abstract available
     
     
     
115. BLOETHNER S , Hemminki K, Thirumaran RK, Chen B, et al
     Differences in global gene expression in melanoma cell lines with and without homozygous deletion of the CDKN2A locus genes.
     Melanoma Res. 2006;16:297-307.
     PubMed     Related articles    Abstract available
     
     
     
116. PAVEY S , Zuidervaart W, van Nieuwpoort F, Packer L, et al
     Increased p21-activated kinase-1 expression is associated with invasive potential in uveal melanoma.
     Melanoma Res. 2006;16:285-96.
     PubMed     Related articles    Abstract available
     
     
     
117. KUMAR SM , Yu H, Fong D, Acs G, et al
     Erythropoietin activates the phosphoinositide 3-kinase/Akt pathway in human melanoma cells.
     Melanoma Res. 2006;16:275-83.
     PubMed     Related articles    Abstract available
     
     
     
118. POYNTER JN , Elder JT, Fullen DR, Nair RP, et al
     BRAF and NRAS mutations in melanoma and melanocytic nevi.
     Melanoma Res. 2006;16:267-273.
     PubMed     Related articles    Abstract available
     
     
     
119. WILLIAMS HA , Fritschi L, Beauchamp C, Katris P, et al
     Evaluating the usefulness of self-reported risk factors in a skin cancer screening program.
     Melanoma Res. 2006;16:341-5.
     PubMed     Related articles    Abstract available
     
     
     June 2006
120. LEJEUNE FJ , Monnier Y, Ruegg C
     Complete and long-lasting regression of disseminated multiple skin melanoma metastases under treatment with cyclooxygenase-2 inhibitor.
     Melanoma Res. 2006;16:263-265.
     PubMed     Related articles    Abstract available
     
     
     
121. KURUL S , Aykan F, Tas F
     Penile metastasis of cutaneous malignant melanoma: a true hematogenous spread?: Case report and review of the literature.
     Melanoma Res. 2006;16:259-61.
     PubMed     Related articles    Abstract available
     
     
     
122. O'NEILL PA , Butt M, Eswar CV, Gillis P, et al
     A prospective single arm phase II study of dacarbazine and treosulfan as first-line therapy in metastatic uveal melanoma.
     Melanoma Res. 2006;16:245-248.
     PubMed     Related articles    Abstract available
     
     
     
123. KUZBICKI L , Gajo B, Chwirot BW
     Different expression of lysosome-associated membrane protein-1 in human melanomas and benign melanocytic lesions.
     Melanoma Res. 2006;16:235-43.
     PubMed     Related articles    Abstract available
     
     
     
124. BUSCHER K , Hahn S, Hofmann M, Trefzer U, et al
     Expression of the human endogenous retrovirus-K transmembrane envelope, Rec and Np9 proteins in melanomas and melanoma cell lines.
     Melanoma Res. 2006;16:223-34.
     PubMed     Related articles    Abstract available
     
     
     
125. SADEJ R , Spychala J, Skladanowski AC
     Expression of ecto-5'-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma.
     Melanoma Res. 2006;16:213-222.
     PubMed     Related articles    Abstract available
     
     
     
126. SHELLMAN YG , Makela M, Norris DA
     Induction of secreted matrix metalloproteinase-9 activity in human melanoma cells by extracellular matrix proteins and cytokines.
     Melanoma Res. 2006;16:207-11.
     PubMed     Related articles    Abstract available
     
     
     
127. ZANETTI R , Loria D, Rosso S
     Melanoma, Parkinson's disease and levodopa: causal or spurious link? A review of the literature.
     Melanoma Res. 2006;16:201-6.
     PubMed     Related articles    Abstract available
     
     
     
128. JASTRZEBSKI T , Sommer A, Swierblewski M, Lass P, et al
     Possibilities of improving the parameters of hyperthermia in regional isolated limb perfusion using epidural bupivacaine and accurate temperature measurement of the three layers of limb tissue.
     Melanoma Res. 2006;16:249-57.
     PubMed     Related articles    Abstract available
     
     
     April 2006
129. OMHOLT K , Krockel D, Ringborg U, Hansson J, et al
     Mutations of PIK3CA are rare in cutaneous melanoma.
     Melanoma Res. 2006;16:197-200.
     PubMed     Related articles    Abstract available
     
     
     
130. HEMMINKI K , Chen B
     Familial risks for eye melanoma and retinoblastoma: results from the Swedish Family-Cancer Database.
     Melanoma Res. 2006;16:191-5.
     PubMed     Related articles    Abstract available
     
     
     
131. IYATOMI H , Oka H, Saito M, Miyake A, et al
     Quantitative assessment of tumour extraction from dermoscopy images and evaluation of computer-based extraction methods for an automatic melanoma diagnostic system.
     Melanoma Res. 2006;16:183-90.
     PubMed     Related articles    Abstract available
     
     
     
132. CONCETTA FARGNOLI M , Altobelli E, Keller G, Chimenti S, et al
     Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study.
     Melanoma Res. 2006;16:175-182.
     PubMed     Related articles    Abstract available
     
     
     
133. WANKOWICZ-KALINSKA A , Mailliard RB, Olson K, Graham F, et al
     Accumulation of low-avidity anti-melanocortin receptor 1 (anti-MC1R) CD8+ T cells in the lesional skin of a patient with melanoma-related depigmentation.
     Melanoma Res. 2006;16:165-174.
     PubMed     Related articles    Abstract available
     
     
     
134. LARKIN JM , Norsworthy PJ, A'hern RP, Eisen TG, et al
     Anti-alphaGal-dependent complement-mediated cytotoxicity in metastatic melanoma.
     Melanoma Res. 2006;16:157-163.
     PubMed     Related articles    Abstract available
     
     
     
135. GYORFFY B , Serra V, Materna V, Schafer R, et al
     Analysis of gene expression profiles in melanoma cells with acquired resistance against antineoplastic drugs.
     Melanoma Res. 2006;16:147-155.
     PubMed     Related articles    Abstract available
     
     
     
136. TREFZER U , Hofmann M, Reinke S, Guo YJ, et al
     Concordant loss of melanoma differentiation antigens in synchronous and asynchronous melanoma metastases: implications for immunotherapy.
     Melanoma Res. 2006;16:137-145.
     PubMed     Related articles    Abstract available
     
     
     
137. MAYORGA ME , Sanchis D, Perez de Santos AM, Velasco A, et al
     Antiproliferative effect of STI571 on cultured human cutaneous melanoma-derived cell lines.
     Melanoma Res. 2006;16:127-135.
     PubMed     Related articles    Abstract available
     
     
     
138. SONG J , Wang J, Yang J, Jiang C, et al
     Influence of angiogenin on the growth of A375 human melanoma cells and the expression of basic fibroblast growth factor.
     Melanoma Res. 2006;16:119-26.
     PubMed     Related articles    Abstract available
     
     
     
139. HALLBERG O
     A theory and model to explain the skin melanoma epidemic.
     Melanoma Res. 2006;16:115-8.
     PubMed     Related articles    Abstract available
     
     
     
140. ZUNKER K , Epplen JT, Schartl M
     Genomic stability in malignant melanoma of Xiphophorus.
     Melanoma Res. 2006;16:105-13.
     PubMed     Related articles    Abstract available
     
     
     
141. THOMAS NE
     BRAF somatic mutations in malignant melanoma and melanocytic naevi.
     Melanoma Res. 2006;16:97-103.
     PubMed     Related articles    Abstract available
     
     
     February 2006
142. FRIEDMAN T , Wohl Y, Levin A, Levi Y, et al
     Multiple common naevi in Israeli adolescents.
     Melanoma Res. 2006;16:89-92.
     PubMed     Related articles    Abstract available
     
     
     
143. SARANGARAJAN R , Apte SP
     The polymerization of melanin: a poorly understood phenomenon with egregious biological implications.
     Melanoma Res. 2006;16:3-10.
     PubMed     Related articles    Abstract available
     
     
     August 2005
144. FINK AM , Weihsengruber F, Spangl B, Feichtinger H, et al
     S-classification of sentinel lymph node biopsy predicts the results of complete regional lymph node dissection.
     Melanoma Res. 2005;15:267-71.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: